Investment analysts at Kepler Capital Markets assumed coverage on shares of Genus plc (LON:GNS) in a note issued to investors on Tuesday, November 7th. The brokerage set a “hold” rating and a GBX 2,353 ($30.95) price target on the stock. Kepler Capital Markets’ price target points to a potential upside of 5.42% from the stock’s previous close.
Several other research firms have also recently weighed in on GNS. Peel Hunt reiterated a “buy” rating and issued a GBX 2,600 ($34.20) price target on shares of Genus in a report on Monday, October 9th. Liberum Capital reiterated a “hold” rating and issued a GBX 2,100 ($27.62) price target on shares of Genus in a report on Monday, October 9th. N+1 Singer upgraded shares of Genus to a “buy” rating and upped their price target for the company from GBX 1,844 ($24.25) to GBX 2,485 ($32.68) in a report on Monday, October 30th. Finally, Numis Securities Ltd restated a “hold” rating and set a GBX 1,815 ($23.87) target price on shares of Genus in a report on Thursday, September 7th. Four equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of GBX 2,270.60 ($29.86).
Genus (LON:GNS) opened at GBX 2,232 ($29.36) on Tuesday. Genus has a 1-year low of GBX 1,652 ($21.73) and a 1-year high of GBX 2,500 ($32.88).
Genus plc is an animal genetics company, which provides farmers with genetics that enable them to produce animal protein, in the form of meat and milk. The Company’s segments include Genus PIC, Genus ABS, Genus Asia, and Research and Development. The Genus PIC segment is engaged in porcine sales business, excluding Asia, and serves porcine customers in North America, Latin America and Europe.
Receive News & Ratings for Genus plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus plc and related companies with our FREE daily email newsletter.